ArticleBMJ open diabetes research & care2023

Dipeptidyl peptidase-4 inhibitors and the risk of skin cancer among patients with type 2 diabetes: a UK population-based cohort study.

Richeek Pradhan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.